Trial intelligence / Profile preview

Allopurinol for persistent allergic asthma

2016-000164-42Phase 4Terminated

Sponsor
University of Dundee
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of allopurinol in allergic asthma and asthma, sponsored by University of Dundee. Primary endpoint: Mannitol PD15. Started Jul 2019; status: terminated.

02

Drugs

allopurinol
03

Conditions

allergic asthmaasthma

Beyond the preview

Go deeper on 2016-000164-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000164-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call